Akihiko Nunomura Selected Research

Akihiko Nunomura Research Topics

Disease

49	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2000
17	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017 - 01/2002
9	Parkinson Disease (Parkinson's Disease) 01/2017 - 03/2002
8	Cognitive Dysfunction 01/2017 - 01/2006
7	Dementia (Dementias) 02/2013 - 11/2002
6	Amyloid Plaque 05/2014 - 05/2002
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 05/2002
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2013 - 03/2002
3	Prodromal Symptoms 01/2020 - 03/2012
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 05/2008 - 09/2005
2	Treatment-Resistant Depressive Disorder 08/2021 - 01/2021
2	Inflammation (Inflammations) 01/2020 - 01/2009
2	Mental Disorders (Mental Disorder) 01/2018 - 01/2014
2	Stroke (Strokes) 01/2017 - 01/2002
2	Down Syndrome (Down's Syndrome) 01/2013 - 01/2006
1	Movement Disorders (Movement Disorder) 08/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Long QT Syndrome 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2014
1	Psychotic Disorders (Schizoaffective Disorder) 01/2014
1	Atrophy 04/2007
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2006
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2006
1	Subacute Sclerosing Panencephalitis (SSPE) 01/2006
1	Scrapie 09/2005
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 09/2005
1	Multiple System Atrophy 03/2002
1	Ischemia 01/2002
1	Atherosclerosis 01/2002
1	Arthritis (Polyarthritis) 01/2002

Drug/Important Bio-Agent (IBA)

12	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2002
12	Amyloid beta-PeptidesIBA 09/2010 - 05/2002
10	AntioxidantsIBA 01/2017 - 04/2005
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
7	Nucleic AcidsIBA 01/2014 - 03/2002
6	Amyloid (Amyloid Fibrils)IBA 01/2017 - 06/2007
5	MetalsIBA 01/2020 - 07/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 01/2002
4	8-hydroxyguanosineIBA 03/2012 - 11/2002
4	Free RadicalsIBA 01/2010 - 02/2007
4	IronIBA 01/2010 - 07/2004
3	LipidsIBA 01/2014 - 01/2010
3	NucleosidesIBA 03/2012 - 11/2002
2	EnzymesIBA 01/2014 - 05/2007
2	Mitochondrial DNA (mtDNA)IBA 06/2013 - 04/2012
2	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 03/2002
2	Heme Oxygenase-1IBA 01/2010 - 09/2005
2	Oxidants (Oxidizing Agents)IBA 12/2009 - 04/2005
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2009 - 10/2004
2	CopperIBA 11/2007 - 07/2004
2	Thioctic Acid (Lipoic Acid)IBA 11/2007 - 06/2007
2	CytochromesIBA 11/2007 - 06/2007
2	LipofuscinIBA 11/2007 - 06/2007
2	Protein Kinases (Protein Kinase)IBA 05/2007 - 10/2003
2	Presenilin-1IBA 10/2004 - 03/2000
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2020
1	Chlorpromazine (Thorazine)FDA Link 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Complement C5 (Complement 5)IBA 01/2018
1	UCP0054278IBA 01/2017
1	Proline Oxidase (Proline Dehydrogenase)IBA 01/2014
1	Neuregulin-1 (Neuregulin 1)IBA 01/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2012
1	Peptides (Polypeptides)IBA 03/2010
1	SugarsIBA 01/2010
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2007
1	Ascorbate OxidaseIBA 11/2007
1	ZincIBA 11/2007
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2007
1	amyloid beta-protein (1-42)IBA 07/2006
1	PrionsIBA 09/2005
1	Peptide Hydrolases (Proteases)FDA Link 09/2005
1	Prion ProteinsIBA 09/2005
1	Ribosomal RNAIBA 06/2005
1	AldehydesIBA 06/2005
1	Advanced Glycation End ProductsIBA 06/2005
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 06/2005
1	hexitolIBA 06/2005
1	Lysine (L-Lysine)FDA Link 06/2005
1	Protein AggregatesIBA 04/2005
1	tau Proteins (tau Protein)IBA 04/2005
1	AntibodiesIBA 03/2005
1	EpitopesIBA 03/2005
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2004
1	Heavy MetalsIBA 07/2004
1	Hydroxyl RadicalIBA 07/2004

Therapy/Procedure

3	Therapeutics 07/2009 - 06/2006
2	Transcranial Magnetic Stimulation 08/2021 - 01/2021
1	Immunotherapy 06/2006